Spine Metastasis in Elderly

Encouraging Results for Better Survival

Quentin Beaufort, MD; Louis-Marie Terrier, MD; Arnaud Dubory, MD, PhD; Louis-Romée Le Nail, MD; Ann-Rose Cook, MD; Joseph Cristini, MD; Kévin Buffenoir, MD, PhD; Hugues Pascal-Moussellard, MD, PhD; Alexandre Carpentier, MD, PhD; Bertrand Mathon, MD; Aymeric Amelot, MD, PhD


Spine. 2021;46(11):751-759. 

In This Article


Prognosis factors of survival in elderly patients seem to be the same as those in the general population such as primary cancer histology, neurological status, WHO status and epiduritis. Age >80 years' old also appears to be an independent poor prognosis factor. To date, treatment options are palliative for patients with SpM, therefore, to be beneficial (surgery in particular) they should aim to improve quality of life. Our data suggest that bracing is associated with lower survival. Concerning professional health care guidelines for patients with SpM, no evidence is available concerning the effectiveness of spinal bracing. We believe that surgery should be considered, regardless of the age of the patient.